Clinical (prescription) cannabis products have been rescheduled in the UK in 2018 — this allowed professional Health professionals to prescribe cannabis-based mostly medicines in a very constrained list of conditions. Access via the NHS stays tightly restricted: cannabis-based solutions are often only prescribed by a expert marketing consultant a